BioSpace News Archive

Marken announced it has begun producing COVID-19 test kits in its Miami facility as an extension of its global supply chain solutions offering.

Aurinia Pharmaceuticals Inc. announced that additional safety data from the completed AURORA pivotal trial of voclosporin were shared at the European Renal Association-European Dialysis and Transplant Association 2020 Virtual Congress in an oral presentation given by nephrologist Dawn Caster, M.D., Assistant Professor of Medicine at the University of Louisville School of Medicine.

New diagnostic test for MSI in solid tumors can inform physicians on immuno-oncology therapies, and can guide treatment decisions for patients with Lynch-associated cancers

Avacta Group plc, the developer of Affimer biotherapeutics and reagents, is pleased to announce that a BAMSTM diagnostic test for the COVID-19 infection, being developed with its partner Adeptrix, has reached prototype stage and can detect the coronavirus spike protein in model samples in the concentration range appropriate for a clinical diagnostic test.

The ALS Association and I AM ALS announced that the organizations have awarded a combined grant of $500,000 to BrainStorm Cell Therapeutics, a biotechnology company, to support an amyotrophic lateral sclerosis biomarker research study.

Collaboration to evaluate comprehensive real-world datasets for their potential to inform FDA’s response to COVID-19

Alphamab Oncology (stock code: 9966 HK) announced that Jiangsu Alphamab Biopharmaceuticals Co., Ltd. (“Jiangsu Alphamab”), a wholly-owned subsidiary of the Company, has entered a partnership agreement with Institut Pasteur of Shanghai, Chinese Academy of Sciences (“Institut Pasteur Shanghai”)

Mesa Laboratories, Inc. (NASDAQ: MLAB) (“Mesa Labs”) today announced the pricing of an underwritten public offering of 600,000 shares of its common stock at a public offering price of $225.00 per share for gross proceeds of approximately $135 million before deducting underwriting discounts and commissions and other estimated offering expenses.

Ardelyx, Inc. announced that on June 8, 2020, the compensation committee of the Company’s Board of Directors granted a non-qualified stock option award to purchase 195,017 shares of its common stock and a restricted stock unit award for 10,000 shares in connection with the commencement of employment of its new Chief Financial Officer, Justin Renz

OnLume Inc., a Madison, Wisconsin-based medical imaging company with unique technology for improving precision in the operating room, has announced the appointment of James A. Bowman as Chief Executive Officer.